Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is it time to move to multidrug combinations?

James L Pool1

  • 1Departments of Medicine and Pharmacology, Center for Experimental Therapeutics, Baylor College of Medicine, Houston, Texas 77030, USA. jpool@bcm.tmc.edu

American Journal of Hypertension
|November 20, 2003
PubMed
Summary

Aggressive blood pressure control is vital for cardiovascular and renal health. Combining multiple medications, especially for patients with diabetes or kidney disease, offers better outcomes and fewer side effects than monotherapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of angiotensin receptor blockade on insulin sensitivity and endothelial function in abdominally obese hypertensive patients with impaired fasting glucose.

Clinical science (London, England : 1979)·2011
Same author

Clinical role of direct renin inhibition in hypertension.

American journal of therapeutics·2011
Same author

AJC Editor's consensus: Selective and nonselective nonsteroidal anti-inflammatory drugs and cardiovascular risk.

The American journal of cardiology·2010
Same author

The role of baseline blood pressure in guiding treatment choice: a secondary analysis of the use of valsartan/hydrochlorothiazide as initial therapy in hypertensive adults in a randomized, double-blind, placebo-controlled trial.

Clinical drug investigation·2009
Same author

The Editor's Roundtable: Endothelial dysfunction in cardiovascular disease.

The American journal of cardiology·2008
Same author

Direct renin inhibition: focus on aliskiren.

Journal of managed care pharmacy : JMCP·2007

Area of Science:

  • Cardiology
  • Nephrology
  • Pharmacology

Background:

  • Aggressive blood pressure (BP) control significantly reduces cardiovascular and renal risks.
  • Many hypertension patients require multiple drugs for adequate BP management.
  • Hypertension with diabetes or renal disease necessitates lower BP targets and often three or more medications.

Purpose of the Study:

  • To highlight the importance of multidrug combinations in hypertension management.
  • To emphasize the effectiveness of lower doses of multiple agents over higher doses of a single agent.
  • To underscore the growing need for understanding combination therapies due to rising diabetes and renal disease prevalence.

Main Methods:

  • Review of clinical benefits of aggressive BP control.

Related Experiment Videos

  • Analysis of treatment challenges in patients with comorbidities.
  • Discussion of combination therapy principles in hypertension.

    • Main Results:

    • Monotherapy often fails to achieve target BP levels.
    • Multidrug regimens are more effective and safer than high-dose monotherapy.
    • Combination therapy is increasingly crucial for managing complex hypertension cases.

    Conclusions:

    • Effective use of specific drug combinations is essential for hypertension treatment strategies.
    • Multidrug combinations are key to achieving target BP in a growing patient population.
    • Understanding combination therapy improves cardiovascular and renal outcomes in hypertensive patients.